2024. Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy. Voprosy onkologii. 70, 4 (Sep. 2024), 677–684. DOI:https://doi.org/10.37469/0507-3758-2024-70-4-677-684.